Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | PPIA | P62937 | 10/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25720195 | 0.91 | HSP90AA1 (0.53) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL24054830 | 0.90 | HSP90AA1 (0.61) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL24054844 | 0.83 | HSP90AA1 (0.65) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL25720097 | 0.79 | KDM4E (0.64) | KDM4ESMN1; SMN2ALDH1A1LMNAUSP2 | |
| SCHEMBL25720201 | 0.79 | HPGD (0.60) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL25720176 | 0.78 | HSP90AA1 (0.63) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL25720179 | 0.78 | HSP90AA1 (0.77) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL25720792 | 0.76 | HSP90AA1 (0.59) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL24054922 | 0.75 | MEN1 (0.72) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL25720819 | 0.75 | KDM4E (0.49) | HSP90AA1ALOX15KDM4ESMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203003-A1 | Notch Inhibitors and Uses Thereof | STEMSYNERGY THERAPEUTICS, INC. | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203003-A1 | Notch Inhibitors and Uses Thereof | NOTCH1, NOTCH2, NOTCH4 | HSP90AA1 4749/4885ALOX15 1130/4885PPIA 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.